Verified peer comparison
Sinovac Biotech vs MEDIFAST Financial Comparison
Direct answer
Sinovac Biotech and MEDIFAST are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Sinovac Biotech email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Sinovac Biotech Revenue
- 386,013,000 USD
- MEDIFAST Revenue
- 385,788,000 USD
- Sinovac Biotech Operating income
- -291,322,000 USD
- MEDIFAST Operating income
- -14,213,000 USD